Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 20;27(5):taaa116.
doi: 10.1093/jtm/taaa116.

Detection of SARS-CoV-2 RNA in commercial passenger aircraft and cruise ship wastewater: a surveillance tool for assessing the presence of COVID-19 infected travellers

Warish Ahmed  1 , Paul M Bertsch  1 , Nicola Angel  2 , Kyle Bibby  3 , Aaron Bivins  3 , Leanne Dierens  2 , Janette Edson  2 , John Ehret  4 , Pradip Gyawali  5 , Kerry A Hamilton  6 , Ian Hosegood  4 , Philip Hugenholtz  2 , Guangming Jiang  7 , Masaaki Kitajima  8 , Homa T Sichani  9 , Jiahua Shi  7 , Katja M Shimko  9 , Stuart L Simpson  10 , Wendy J M Smith  11 , Erin M Symonds  12 , Kevin V Thomas  9 , Rory Verhagen  9 , Julian Zaugg  2 , Jochen F Mueller  9
Affiliations

Detection of SARS-CoV-2 RNA in commercial passenger aircraft and cruise ship wastewater: a surveillance tool for assessing the presence of COVID-19 infected travellers

Warish Ahmed et al. J Travel Med. .

Abstract

Background: Wastewater-based epidemiology (WBE) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can be an important source of information for coronavirus disease 2019 (COVID-19) management during and after the pandemic. Currently, governments and transportation industries around the world are developing strategies to minimize SARS-CoV-2 transmission associated with resuming activity. This study investigated the possible use of SARS-CoV-2 RNA wastewater surveillance from airline and cruise ship sanitation systems and its potential use as a COVID-19 public health management tool.

Methods: Aircraft and cruise ship wastewater samples (n = 21) were tested for SARS-CoV-2 using two virus concentration methods, adsorption-extraction by electronegative membrane (n = 13) and ultrafiltration by Amicon (n = 8), and five assays using reverse-transcription quantitative polymerase chain reaction (RT-qPCR) and RT-droplet digital PCR (RT-ddPCR). Representative qPCR amplicons from positive samples were sequenced to confirm assay specificity.

Results: SARS-CoV-2 RNA was detected in samples from both aircraft and cruise ship wastewater; however concentrations were near the assay limit of detection. The analysis of multiple replicate samples and use of multiple RT-qPCR and/or RT-ddPCR assays increased detection sensitivity and minimized false-negative results. Representative qPCR amplicons were confirmed for the correct PCR product by sequencing. However, differences in sensitivity were observed among molecular assays and concentration methods.

Conclusions: The study indicates that surveillance of wastewater from large transport vessels with their own sanitation systems has potential as a complementary data source to prioritize clinical testing and contact tracing among disembarking passengers. Importantly, sampling methods and molecular assays must be further optimized to maximize detection sensitivity. The potential for false negatives by both wastewater testing and clinical swab testing suggests that the two strategies could be employed together to maximize the probability of detecting SARS-CoV-2 infections amongst passengers.

Keywords: COVID-19; SARS-CoV-2; WBE; aircraft; cruise ship; enveloped viruses; wastewater.

PubMed Disclaimer

References

    1. Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in the real-time. Lancet Infect Dis 2020; 20:533–4. - PMC - PubMed
    1. Zhou P, Yang XL, Wang XG et al. . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579:270–3. - PMC - PubMed
    1. Lewnard JA, Lo NC. Scientific and ethical basis for social-distancing interventions against COVID-19. Lancet Infect Dis 2020; 30190-0:S1473–3099. - PMC - PubMed
    1. Barrot JN, Grassi B, Julien S. Sectoral effects of social distancing. SSRN 2020. doi: 10.2139/ssrn.3569446. - DOI
    1. Thunstorm L, Newbold S, Finnoff D et al. . The benefits and costs of using social distancing to flatten the curve for COVID-19. J Benefit Cost Anal 2020. doi: 10.1017/bca.2020.12. - DOI